Analysts predict that Flexion Therapeutics Inc (NASDAQ:FLXN) will announce sales of $18.07 million for the current quarter, Zacks reports. Three analysts have issued estimates for Flexion Therapeutics’ earnings. The lowest sales estimate is $16.50 million and the highest is $19.00 million. Flexion Therapeutics posted sales of $6.99 million during the same quarter last year, which […]
